MARAVAI LIFESCIENCES HOLDINGS, INC.

For the period ended Dec 31, 2024. Filed Mar 18, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 18, 2025

MRVI$7.86-2.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except par value)

	December 31,
	2024	2023
Assets
Current assets:
Cash and cash equivalents	$322,399	$574,962
Accounts receivable, net	38,520	54,605
Inventory	50,082	51,397
Prepaid expenses and other current assets	18,145	18,948
Total current assets	429,146	699,912
Property and equipment, net	164,474	162,900
Goodwill	159,878	326,029
Intangible assets, net	194,957	220,987
Other assets	59,789	77,622
Total assets	$1,008,244	$1,487,450
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$11,957	$10,729
Accrued expenses and other current liabilities	36,407	60,237
Deferred revenue	2,375	3,360
Current portion of payable to related parties pursuant to the Tax Receivable Agreement	—	7,069
Current portion of long-term debt	5,440	5,440
Current portion of finance lease liabilities	792	633
Total current liabilities	56,971	87,468
Long-term debt, less current portion	290,492	518,707
Finance lease liabilities, less current portion	31,106	31,897
Other long-term liabilities	52,466	59,494
Total liabilities	431,035	697,566
Commitments and contingencies (Note 9)
Stockholders’ equity:
Class A common stock, $0.01 par value - 500,000 shares authorized; 141,976 and 132,228 shares issued and outstanding as of December 31, 2024 and 2023, respectively	1,420	1,322
Class B common stock, $0.01 par value - 256,856 and 300,000 shares authorized as of December 31, 2024 and 2023, respectively; 110,684 and 119,094 shares issued and outstanding as of December 31, 2024 and 2023, respectively	1,107	1,191
Additional paid-in capital	181,874	128,503
Retained earnings	140,891	285,737
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	325,292	416,753
Non-controlling interest	251,917	373,131
Total stockholders’ equity	577,209	789,884
Total liabilities and stockholders’ equity	$1,008,244	$1,487,450

The accompanying notes are an integral part of these consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.